Phreesia, Inc. (NYSE:PHR) Receives Average Rating of "Hold" from Brokerages

Key Points

• Analysts collectively rate Phreesia “Hold”: Of 19 analysts, 10 recommend holding, eight recommend buying, and one recommends selling. The average 12-month price target is $14.00, above the stock’s reported $10.09 price.
• Phreesia’s latest quarterly revenue reached $129.46 million, up 10.4% year over year and slightly above estimates, but adjusted earnings of $0.03 per share missed consensus by $0.06.
• The company is primarily institutionally owned, with investors holding 92.1% of shares. An insider recently sold shares under a pre-arranged plan to cover tax obligations related to vested equity awards.

Phreesia, Inc. (NYSE:PHR - Get Free Report) has been given a consensus recommendation of "Hold" by the nineteen analysts that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eight have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is $14.00.

A number of equities analysts have recently issued reports on PHR shares. Weiss Ratings lowered shares of Phreesia from a "sell (d+)" rating to a "sell (d)" rating in a research report on Friday, September 4th. Wall Street Zen lowered shares of Phreesia from a "buy" rating to a "hold" rating in a report on Saturday, September 5th. Needham & Company LLC restated a "buy" rating and issued a $14.00 price objective on shares of Phreesia in a research report on Monday, August 31st. Canaccord Genuity Group reaffirmed a "buy" rating and set a $16.00 price objective on shares of Phreesia in a report on Thursday, September 3rd. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $19.00 target price on shares of Phreesia in a research note on Thursday, September 3rd.

Phreesia Trading Down 2.7%

Shares of PHR opened at $10.09 on Friday. The stock has a fifty day moving average price of $11.08 and a two-hundred day moving average price of $10.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia has a 52-week low of $7.77 and a 52-week high of $24.25. The company has a market cap of $625.99 million, a price-to-earnings ratio of 59.33 and a beta of 0.84.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.06). The company had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company earned $0.01 EPS. Analysts predict that Phreesia will post 0.33 EPS for the current fiscal year.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 6,662 shares of Phreesia stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the completion of the sale, the general counsel directly owned 266,574 shares in the company, valued at $2,687,065.92. This trade represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Phreesia

Several institutional investors and hedge funds have recently added to or reduced their stakes in PHR. Sequoia Financial Advisors LLC acquired a new stake in shares of Phreesia during the 2nd quarter worth approximately $159,000. Integrated Wealth Concepts LLC lifted its holdings in Phreesia by 37.2% in the second quarter. Integrated Wealth Concepts LLC now owns 14,129 shares of the company's stock valued at $145,000 after buying an additional 3,834 shares during the period. Allworth Financial LP boosted its stake in Phreesia by 78.3% in the second quarter. Allworth Financial LP now owns 5,613 shares of the company's stock valued at $58,000 after acquiring an additional 2,465 shares during the last quarter. Corient Private Wealth LP grew its holdings in Phreesia by 451.7% during the 2nd quarter. Corient Private Wealth LP now owns 148,290 shares of the company's stock worth $1,526,000 after acquiring an additional 121,413 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Phreesia during the 2nd quarter valued at $1,038,000. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc is a healthcare technology company that provides software and services designed to help healthcare organizations manage patient intake and engagement. Its platform digitizes administrative and clinical processes that traditionally rely on paper forms, manual data entry, and separate payment systems.

The company's offerings include digital patient check-in and registration, insurance and demographic information collection, appointment-related communications, electronic forms and consent management, patient surveys, and payment processing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.